PL168456B1 - Sposób wytwarzania cyklopeptydów PL PL PL - Google Patents

Sposób wytwarzania cyklopeptydów PL PL PL

Info

Publication number
PL168456B1
PL168456B1 PL91299317A PL29931791A PL168456B1 PL 168456 B1 PL168456 B1 PL 168456B1 PL 91299317 A PL91299317 A PL 91299317A PL 29931791 A PL29931791 A PL 29931791A PL 168456 B1 PL168456 B1 PL 168456B1
Authority
PL
Poland
Prior art keywords
arg
gly
ile
phe
fmoc
Prior art date
Application number
PL91299317A
Other languages
English (en)
Polish (pl)
Inventor
Gerd Schnorrenberg
Rainer Palluk
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19904032268 external-priority patent/DE4032268A1/de
Priority claimed from DE19904032269 external-priority patent/DE4032269A1/de
Priority claimed from DE19904032271 external-priority patent/DE4032271A1/de
Priority claimed from DE19914117733 external-priority patent/DE4117733A1/de
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of PL168456B1 publication Critical patent/PL168456B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C07K14/582—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL91299317A 1990-10-11 1991-10-10 Sposób wytwarzania cyklopeptydów PL PL PL PL168456B1 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19904032268 DE4032268A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19904032269 DE4032269A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19904032271 DE4032271A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19914117733 DE4117733A1 (de) 1991-05-30 1991-05-30 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PCT/EP1991/001934 WO1992006998A1 (de) 1990-10-11 1991-10-10 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
PL168456B1 true PL168456B1 (pl) 1996-02-29

Family

ID=27435038

Family Applications (1)

Application Number Title Priority Date Filing Date
PL91299317A PL168456B1 (pl) 1990-10-11 1991-10-10 Sposób wytwarzania cyklopeptydów PL PL PL

Country Status (12)

Country Link
EP (1) EP0552238A1 (de)
JP (1) JPH06501950A (de)
KR (1) KR930702395A (de)
AU (1) AU8736691A (de)
CA (1) CA2089747A1 (de)
CZ (1) CZ61893A3 (de)
FI (1) FI931499A0 (de)
HU (1) HUT63859A (de)
IE (1) IE913582A1 (de)
PL (1) PL168456B1 (de)
SK (1) SK32693A3 (de)
WO (1) WO1992006998A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
AU769791B2 (en) * 1998-06-24 2004-02-05 New York University Novel Staphylococcus peptides for bacterial interference
US6337385B1 (en) 1998-06-24 2002-01-08 The Rockefeller University Staphylococcus peptides for bacterial interference
FR2797689B1 (fr) * 1999-08-16 2003-06-27 Pasteur Sanofi Diagnostics Utilisation de composes synthetiques pour des immunodosages
US6455587B1 (en) * 2000-03-15 2002-09-24 Pharmacor Inc. Amino acid derivatives as HIV aspartyl protease inhibitors
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
CA2632095A1 (en) 2005-11-30 2007-06-07 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
AU2007233116B2 (en) 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
CA2647146A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
WO2008078200A2 (en) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
JP5649825B2 (ja) 2007-01-31 2015-01-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 安定化させたｐ５３ペプチドおよびその使用法
KR101525754B1 (ko) 2007-03-28 2015-06-09 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
CN108570097A (zh) 2010-08-13 2018-09-25 爱勒让治疗公司 拟肽大环化合物
MX358886B (es) 2011-10-18 2018-08-31 Aileron Therapeutics Inc Macrociclos peptidomimeticos.
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
SG11201404648PA (en) 2012-02-15 2014-09-26 Aileron Therapeutics Inc Peptidomimetic macrocycles
EP2914256B1 (de) 2012-11-01 2019-07-31 Aileron Therapeutics, Inc. Disubstituierte aminosäuren und verfahren zur herstellung und verwendung davon
US10736932B2 (en) * 2014-05-20 2020-08-11 Ohio State Innovation Foundation Small molecule Ras inhibitors
CN112972378A (zh) 2014-09-24 2021-06-18 艾瑞朗医疗公司 拟肽大环化合物及其制剂
JP2017533889A (ja) 2014-09-24 2017-11-16 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその使用
EP3294318A4 (de) 2015-03-20 2019-04-03 Aileron Therapeutics, Inc. Peptidomimetische makrozyklen und verwendungen davon
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337891C (en) * 1987-12-16 1996-01-02 John Dimaio Anf derivatives with novel bridging
US4935492A (en) * 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
DK380288D0 (da) * 1988-07-07 1988-07-07 Novo Industri As Hidtil ukendet peptider

Also Published As

Publication number Publication date
CA2089747A1 (en) 1992-04-12
IE913582A1 (en) 1992-04-22
FI931499A (fi) 1993-04-02
FI931499A0 (fi) 1993-04-02
HU9301054D0 (en) 1993-07-28
WO1992006998A1 (de) 1992-04-30
AU8736691A (en) 1992-05-20
HUT63859A (en) 1993-10-28
EP0552238A1 (de) 1993-07-28
CZ61893A3 (en) 1994-01-19
SK32693A3 (en) 1993-09-09
KR930702395A (ko) 1993-09-09
JPH06501950A (ja) 1994-03-03

Similar Documents

Publication Publication Date Title
PL168456B1 (pl) Sposób wytwarzania cyklopeptydów PL PL PL
US6472505B1 (en) Peptide parathyroid hormone analogs
US5998375A (en) Nociceptin analogues
CZ282384B6 (cs) Peptidy antagonisující účinky bradykininu, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
EP0214659A2 (de) Peptidderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0794959A1 (de) Aminosäuren zur herstellung von betiden und verfahren zum aufspüren und herstellen von betrol - bibliotheken
US20040122013A1 (en) Analogs of nocicettin
Al-Obeidi et al. Synthesis and biological activities of fatty acid conjugates of a cyclic lactam. alpha.-melanotropin
NO854645L (no) Fremgangsmaate for fremstilling av basiske cykliske peptider.
US4599324A (en) V1-vasopressin antagonists
US4684622A (en) Compositions and methods for producing vasodilation and antioxytocic activity
AU3673699A (en) Pth2 receptor selective compounds
EP1261626A1 (de) Bombesin analoge und deren verwendung zur behandlung von krebs
EP1198478B1 (de) Somatostatin analoge und deren verwendung zur behandlung von krebs
NO862406L (no) Vasopressin-antagonister.
CA2405724C (en) Substance p analogs for the treatment of cancer
Abiko et al. Syntheses of two neuromedin U (NMU) analogues and their comparative reducing food intake effect in rats
DE4032268A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2163114A1 (en) Peptides exhibiting oxytocin antagonistic activity
WO2014075137A1 (en) Peptides incorporating amino-substituted lactams for treatment of retinopathy
AU739557B2 (en) Cyclic peptide analogs of somatostatin
AU700904C (en) Amino acids for making betides and methods of screening and making betide libraries
WO1999022758A1 (en) Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
WO2002000688A1 (fr) Compose peptidique, compositions pharmaceutiques et medicaments contenant ceux-ci comme principe actif